Table 3.
Complete Response | 0/13 (0%) |
Partial Response | 0/13 (0%) |
Stable Disease | 4/13 (31%) |
Disease Control Rate | 4/13 (31%) |
Progression Disease | 9/13 (69%) |
mPFS | 2.2 months (95% CI 1.6–2.8) |
6 month-PFS | 23% |
mOS | 5.6 months (95% CI 0.1–11.9) |
12 month-OS | 38% |
PFS: progression-free survival; OS: overall survival.